Literature DB >> 10698229

Quantitative thallium-201 and technetium 99m sestamibi tomography at rest in detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction.

A Cuocolo1, W Acampa, E Nicolai, L Pace, M Petretta, M Salvatore.   

Abstract

BACKGROUND: This study was designed to determine the most effective quantitative threshold for thallium-201 and technetium 99m sestamibi uptake on tomographic imaging after rest injection for the detection of myocardial viability in patients with chronic myocardial infarction. METHODS AND
RESULTS: Thallium and sestamibi cardiac tomography at rest was performed in 43 patients with chronic myocardial infarction and impaired left ventricular (LV) function undergoing coronary revascularization. In all patients, echocardiography and radionuclide angiography were performed at baseline and repeated 12 months later to evaluate recovery of regional LV function and LV ejection fraction, respectively. Optimal threshold cutoff points to separate reversible from irreversible dysfunction were determined by receiver operating characteristic analysis. When all dysfunctional segments were considered, the best cutoff point in the identification of reversible LV dysfunction for both thallium and sestamibi activity was 67%. When only akinetic or dyskinetic segments were considered, the best cutoff point in the identification of reversible LV dysfunction was 58% for thallium and 55% for sestamibi. In these segments, the area under the receiving operating characteristic curves constructed for thallium and sestamibi activity were 0.74+/-0.05 and 0.75+/-0.04, respectively (P = not significant). LV ejection fraction was 33%+/-7% at baseline and increased to 37%+/-7% after revascularization (P<.0001). A significant relation between the number of akinetic or dyskinetic but viable myocardial segments and revascularization-induced changes in LV ejection fraction was observed for both thallium (r = 0.60, P<.0001) and sestamibi (r = 0.64, P<.0001) imaging.
CONCLUSIONS: In patients with chronic myocardial infarction, quantitative analysis of thallium and sestamibi activity on tomographic imaging at rest predicts recovery of regional and global LV dysfunction after revascularization procedures. The most effective quantitative threshold for detecting reversible LV dysfunction is comparable for thallium and sestamibi tomographic imaging. However, the optimal cutoff point is different for both tracers when all dysfunctional segments are considered or when the analysis is focused only on segments with more severe functional impairment (i.e., akinetic or dyskinetic segments).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698229     DOI: 10.1067/mnc.2000.100706

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  22 in total

1.  Rest-injected thallium-201 imaging for assessing viability of severe asynergic regions.

Authors:  T Mori; K Minamiji; H Kurogane; K Ogawa; Y Yoshida
Journal:  J Nucl Med       Date:  1991-09       Impact factor: 10.057

2.  Extent of myocardial viability in regions of left ventricular dysfunction by rest-redistribution thallium-201 imaging: a powerful predictor of outcome.

Authors:  G A Beller; M Ragosta
Journal:  J Nucl Cardiol       Date:  1998 Jul-Aug       Impact factor: 5.952

3.  Rest-redistribution thallium-201 SPECT to detect myocardial viability.

Authors:  R Sciagrà; G M Santoro; G Bisi; P Pedenovi; P F Fazzini; A Pupi
Journal:  J Nucl Med       Date:  1998-03       Impact factor: 10.057

4.  One-year effect of myocardial revascularization on resting left ventricular function and regional thallium uptake in chronic CAD.

Authors:  A Cuocolo; E Nicolai; M Petretta; C Morisco; N De Luca; M Salvatore; B Trimarco
Journal:  J Nucl Med       Date:  1997-11       Impact factor: 10.057

Review 5.  Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium.

Authors:  V Dilsizian; R O Bonow
Journal:  Circulation       Date:  1993-01       Impact factor: 29.690

6.  The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability.

Authors:  P Marzullo; G Sambuceti; O Parodi
Journal:  J Nucl Med       Date:  1992-11       Impact factor: 10.057

7.  Adenosine technetium-99m-methoxy isobutyl isonitrile myocardial tomography in patients with coronary artery disease: comparison with exercise.

Authors:  A Cuocolo; A Soricelli; L Pace; E Nicolai; L Castelli; A Nappi; M Imbriaco; C Morisco; P J Ell; M Salvatore
Journal:  J Nucl Med       Date:  1994-07       Impact factor: 10.057

8.  Rest technetium 99m-sestamibi tomoscintigraphy in hibernating myocardium.

Authors:  J C Maublant; B Citron; J Lipiecki; D Mestas; P Bailly; A Veyre; C de Riberolles; J Ponsonnaille
Journal:  Am Heart J       Date:  1995-02       Impact factor: 4.749

9.  Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction.

Authors:  G J Kauffman; T S Boyne; D D Watson; W H Smith; G A Beller
Journal:  J Am Coll Cardiol       Date:  1996-06       Impact factor: 24.094

10.  Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary arterial bypass grafting.

Authors:  A S Iskandrian; A H Hakki; S A Kane; I P Goel; E D Mundth; A H Hakki; B L Segal
Journal:  Am J Cardiol       Date:  1983-05-01       Impact factor: 2.778

View more
  11 in total

Review 1.  An overview of radiotracers in nuclear cardiology.

Authors:  W Acampa; C Di Benedetto; A Cuocolo
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

2.  Usefulness of distinct activity thresholds according to baseline regional asynergy for predicting functional recovery in patients with chronic coronary artery disease and left ventricular dysfunction: a study with nitrate-enhanced sestamibi gated SPECT.

Authors:  M Leoncini; G Marcucci; R Sciagrà; F Frascarelli; F Bellandi; M Gallopin; A Mennuti; R P Dabizzi
Journal:  J Nucl Cardiol       Date:  2001 Sep-Oct       Impact factor: 5.952

Review 3.  Quantification of SPECT myocardial perfusion imaging.

Authors:  Wanda Acampa; Wei He; Carmine di Nuzzo; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

4.  Tetrofosmin imaging in the detection of myocardial viability in patients with previous myocardial infarction: comparison with sestamibi and Tl-201 scintigraphy.

Authors:  Wanda Acampa; Alberto Cuocolo; Mario Petretta; Andrea Bruno; Massimo Castellani; Andrea Finzi; Paolo Gerundini
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

5.  Mortality risk associated with ejection fraction differs across resting nuclear perfusion findings.

Authors:  Jamieson M Bourque; Eric J Velazquez; Robert H Tuttle; Linda K Shaw; Christopher M O'Connor; Salvador Borges-Neto
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

6.  Technetium 99m furifosmin regional myocardial uptake in patients with previous myocardial infarction: relation to thallium-201 activity and left ventricular function.

Authors:  A Cuocolo; G Rubini; W Acampa; E Nicolai; L Florimonte; G DiGiovine; A D'Addabbo; M Salvatore
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

7.  Sestamibi SPECT in the detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction: comparison between visual and quantitative analysis.

Authors:  W Acampa; M Petretta; L Florimonte; M S di Santolo; A Cuocolo
Journal:  J Nucl Cardiol       Date:  2000 Sep-Oct       Impact factor: 5.952

8.  Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic imaging by PET.

Authors:  Wei He; Wanda Acampa; Ciro Mainolfi; Francesco Menna; Anna Rita Sorrentino; Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

9.  Clinical characteristics and referral pattern of patients with left ventricular dysfunction and significant coronary artery disease undergoing radionuclide imaging.

Authors:  Jamieson M Bourque; Eric J Velazquez; Salvador Borges-Neto; Linda K Shaw; David J Whellan; Christopher M O'connor
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

10.  Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy.

Authors:  Roxy Senior; Sanjiv Kaul; Usha Raval; Avijit Lahiri
Journal:  J Nucl Cardiol       Date:  2002 Sep-Oct       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.